Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Research Network

Collaboration Network

19 collaborators·65 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Istituto Tumori Milano

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

L. Cavanna, MD

Oncologia Piacenza

Related
1 trials

Shared therapeutic areas:

Metastatic DiseaseCarcinoma, Renal Cell

Worked with same sponsors:

Italian Trial in Medical Oncology
Collaborated on 1 trial
Similarity Score24%

Sergio Bracarda, MD

Oncologia Medica Ospedale di Perugia

Related
1 trials

Shared therapeutic areas:

Metastatic DiseaseCarcinoma, Renal Cell

Worked with same sponsors:

Italian Trial in Medical Oncology
Collaborated on 1 trial
Similarity Score24%

D. Amadori, MD

IOR Ospedale di Forlì

Related
1 trials

Shared therapeutic areas:

Metastatic DiseaseCarcinoma, Renal Cell

Worked with same sponsors:

Italian Trial in Medical Oncology
Collaborated on 1 trial
Similarity Score24%

E. Aitini, MD

Ospedale di Mantova

Related
1 trials

Shared therapeutic areas:

Metastatic DiseaseCarcinoma, Renal Cell

Worked with same sponsors:

Italian Trial in Medical Oncology
Collaborated on 1 trial
Similarity Score24%

C. Porta, MD

Ospedale San Matteo Pavia

Related
1 trials

Shared therapeutic areas:

Metastatic DiseaseCarcinoma, Renal Cell

Worked with same sponsors:

Italian Trial in Medical Oncology
Collaborated on 1 trial
Similarity Score24%

M. Aglietta, MD

Ospedale di Candiolo Torino

Related
1 trials

Shared therapeutic areas:

Metastatic DiseaseCarcinoma, Renal Cell

Worked with same sponsors:

Italian Trial in Medical Oncology
Collaborated on 1 trial
Similarity Score24%

V. Zagonel, MD

Medicina Oncologica - Ospedale Fatebenefratelli - Roma

Related
1 trials

Shared therapeutic areas:

Metastatic DiseaseCarcinoma, Renal Cell

Worked with same sponsors:

Italian Trial in Medical Oncology
Collaborated on 1 trial
Similarity Score24%

G. Fasola, MD

Ospedale di Udine

Related
1 trials

Shared therapeutic areas:

Metastatic DiseaseCarcinoma, Renal Cell

Worked with same sponsors:

Italian Trial in Medical Oncology
Collaborated on 1 trial
Similarity Score24%

A. Bertolini, MD

SOC Oncologia Medica Azienda Ospedaliera Valtellina

Related
1 trials

Shared therapeutic areas:

Metastatic DiseaseCarcinoma, Renal Cell

Worked with same sponsors:

Italian Trial in Medical Oncology
Collaborated on 1 trial
Similarity Score24%

S. Monfardini, MD

Oncologia Ospedale di Padova

Related
1 trials

Shared therapeutic areas:

Metastatic DiseaseCarcinoma, Renal Cell

Worked with same sponsors:

Italian Trial in Medical Oncology
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00609401Phase 2PrincipalInvestigator

Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC)

Metastatic DiseaseRenal Cell Carcinoma
Completed
NCT01444807Phase 2StudyChair

Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the Metastases

Metastatic Renal Cell Carcinoma
Unknown

All 2 trials loaded